Cargando…

460. Ceftriaxone vs. Standard of Care for Definitive Treatment of Methicillin-Susceptible Staphylococcus aureus Infections

BACKGROUND: β-Lactam antibiotics, specifically nafcillin, oxacillin, and cefazolin, have proven efficacy for methicillin-susceptible Staphylococcus aureus (MSSA) infections. Outpatient antimicrobial therapy (OPAT) with these agents is limited due to side effects and multiple doses required per day....

Descripción completa

Detalles Bibliográficos
Autores principales:	Snawerdt, Jessica, Withers, Sarah, Schrank, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810526/ http://dx.doi.org/10.1093/ofid/ofz360.533

Ejemplares similares

1057. Treatment Efficacy of Ceftriaxone vs. Cefazolin for Methicillin-Susceptible Staphylococcus aureus Infections
por: Bhavan, Kavita, et al.
Publicado: (2018)

738. Outcomes of Ceftriaxone Versus Antistaphylococcal Penicillins or Cefazolin for Definitive Therapy of Methicillin-susceptible Staphylococcus aureus Bacteremia
por: Khodadadi, Ryan B, et al.
Publicado: (2022)

266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Mohamed, Adham, et al.
Publicado: (2020)

Ceftriaxone for the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Case Series
por: Lowe, Rachel Amanda, et al.
Publicado: (2017)

730 A Retrospective Comparison of Self – Administered Ceftriaxone vs Cefazolin for Methicillin-Susceptible Staphylococcus Aureus Bacteremia in an Outpatient Antibiotic Therapy Setting.
por: Diamante, Oliver, et al.
Publicado: (2014)

177. Clinical Outcomes of Daptomycin vs. Anti-Staphylococcal β-Lactams in Definitive Treatment of Methicillin-Susceptible Staphylococcus aureus (MSSA) Bloodstream Infections
por: Agnello, Sydney, et al.
Publicado: (2019)

2129. When Is Methicillin-resistant Staphylococcus aureus not Methicillin-resistant Staphylococcus aureus?
por: Gitman, Melissa R, et al.
Publicado: (2019)

Effectiveness and Safety of Ceftriaxone Compared to Standard of Care for Treatment of Bloodstream Infections Due to Methicillin-Susceptible Staphylococcus aureus: A Systematic Review and Meta-Analysis
por: Alsowaida, Yazed Saleh, et al.
Publicado: (2022)

Ceftriaxone as an Alternative Therapy for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia after Initial Clearance of Bloodstream Infection
por: Barber, Katie E., et al.
Publicado: (2021)

850. Outcomes of Patients Discharged on Parenteral Ceftriaxone Compared with Oxacillin or Cefazolin in Methicillin-susceptible Staphylococcal aureus (MSSA) Bloodstream Infections
por: Erik Connor, Lee, et al.
Publicado: (2019)

732. Increase in the Proportion of Hospitalizations in the Setting of Methicillin-Susceptible vs. Resistant Staphylococcus aureus in New York City (NYC)
por: Bromberg, Maria, et al.
Publicado: (2023)

1062. Daptomycin/Ceftaroline in Combination vs. Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Fox, Matthew, et al.
Publicado: (2018)

183. Combination Antibiotic Therapy vs Monotherapy for Methicillin Resistant Staphylococcus aureus Endocarditis
por: Crosby, James M, et al.
Publicado: (2023)

2559. Incidence and Clinical Impact of Discordant Genotypic and Phenotypic Categorization of Methicillin Susceptibility in Staphylococcus aureus Bacteremia
por: Gulliver, Jessica, et al.
Publicado: (2018)

Microbial Susceptibility and Plasmid Profiles of Methicillin-Resistant Staphylococcus aureus and Methicillin-Susceptible S. aureus
por: Shahkarami, Fatemeh, et al.
Publicado: (2014)

947. Evaluating the Outcomes of Infectious Diseases Consultation on methicillin susceptible Staphylococcus aureus Bacteremia
por: Viteri, Alina, et al.
Publicado: (2022)

1455. Cluster of Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections at an Outpatient Surgery Center
por: Bailey, Allison, et al.
Publicado: (2023)

1373. Racial Disparities in Clinical Characteristics and Outcomes for Methicillin Susceptible and Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Mohnasky, Michael C, et al.
Publicado: (2021)

215. Shorter vs. Longer Duration of Treatment in Patients with Ceftriaxone-resistant and Ceftriaxone-susceptible Escherichia coli Bloodstream Infections
por: Mackow, Natalie A, et al.
Publicado: (2023)

2290. Carbapenem vs. Piperacillin–tazobactam Definitive Therapy for Patients with Bloodstream Infections Due to Ceftriaxone Not Susceptible Escherichia coli or Klebsiella species
por: MacVane, Shawn H, et al.
Publicado: (2019)

248. Evaluation of Continuous versus Intermittent Infusion of Nafcillin in the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Williamson, Julie E, et al.
Publicado: (2023)

282. Epidemiological Evaluation of Methicillin-Resistant Staphylococcus aureus (MRSA) and Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia: A Comprehensive Cancer Center’s 10-Year Experience
por: Ford, Charles R, et al.
Publicado: (2020)

Outcomes of Outpatient Parenteral Antimicrobial Therapy With Ceftriaxone for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections—A Single-Center Observational Study
por: Hamad, Yasir, et al.
Publicado: (2020)

Resolution of Staphylococcus aureus (methicillin-resistant Staphylococcus aureus) osteomyelitis by oral linezolid
por: Gomes, PN, et al.
Publicado: (2003)

Transesophageal Echocardiography vs. Transthoracic Echocardiography for Methicillin-Sensitive Staphylococcus aureus and Methicillin-Resistant Staphylococcus aureus Endocarditis
por: Henriquez, Elvis, et al.
Publicado: (2023)

In vitro transfer of methicillin resistance determinants mecA from methicillin resistant Staphylococcus aureus (MRSA) to methicillin susceptible Staphylococcus aureus (MSSA)
por: Bitrus, Asinamai Athliamai, et al.
Publicado: (2017)

1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol
por: Weber, Rachel, et al.
Publicado: (2023)

Staphylococcus aureus Bacteremia in Children: The Effect of Methicillin Resistance
por: Hamdy, Rana F, et al.
Publicado: (2017)

Attributable mortality in critically ill patients with bacteremia involving methicillin susceptible (MSSA) and methicillin resistant Staphylococcus aureus (MRSA)
por: Blot, S, et al.
Publicado: (2001)

1804. Impact of Susceptibility Testing Method on Antibiotic Selection for Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia
por: Bhatt, Mahesh, et al.
Publicado: (2018)

217. Combination Salvage Therapy with Cefazolin Plus Ertapenem for Refractory Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Rose Ulloa, Erlinda, et al.
Publicado: (2019)

852. The Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children: Does It Matter?
por: McNeil, Jonathan C, et al.
Publicado: (2019)

207. High Severity and Mortality Due to Methicillin-Susceptible Staphylococcus aureus Infections in a Colombian Hospital
por: Ordonez Diaz, Karen M, et al.
Publicado: (2019)

1588. Delafloxacin Activity Against Staphylococcus aureus with Reduced Susceptibility or Resistance to Methicillin, Vancomycin, Daptomycin, or Linezolid
por: Saravolatz, Louis D, et al.
Publicado: (2019)

1827. Comparison of clinical outcomes for glycopeptides and beta-lactams in methicillin-susceptible Staphylococcus aureus bloodstream infections
por: La, Yeon Ju, et al.
Publicado: (2022)

2176. A New Rapid Test for Detection of The Cefazolin Inoculum Effect (CIE) in Methicillin-Susceptible Staphylococcus aureus (MSSA)
por: Carvajal, Lina P, et al.
Publicado: (2019)

182. Back to The Future: Increasing Penicillin Susceptibility among Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children
por: McNeil, Jonathon C, et al.
Publicado: (2021)

Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
por: Gern, Benjamin H., et al.
Publicado: (2018)

Intravenous Ceftriaxone Versus Multiple Dosing Regimes of Intravenous Anti-Staphylococcal Antibiotics for Methicillin-Susceptible Staphylococcus aureus (MSSA): A Systematic Review
por: Kamfose, Musaiwale M., et al.
Publicado: (2020)

Assessing the Surrogate Susceptibility of Oxacillin and Cefoxitin for Commonly Utilized Parenteral Agents against Methicillin-Susceptible Staphylococcus aureus: Focus on Ceftriaxone Discordance between Predictive Susceptibility and in Vivo Exposures
por: Kang, Nayon, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dtlvbq1rdta50oi78an92a0407